LCTX
Lineage Cell Therapeutics Inc
NYSE MKT: LCTX · HEALTHCARE · BIOTECHNOLOGY
$1.43
-2.05% today
Updated 2026-05-06
Market cap
$363.98M
P/E ratio
—
P/S ratio
25.01x
EPS (TTM)
$-0.28
Dividend yield
—
52W range
$0 – $2
Volume
1.2M
Lineage Cell Therapeutics Inc (LCTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.26M | $-1.24M | $-1.60M | $-4.26M | $-7.73M | $-13.59M | $-19.68M | $-29.51M | $-38.85M | $-44.54M | $-42.33M | $-30.52M | $-30.88M | $-31.95M | $-19.75M | $-23.56M | $1.06M | $-28.57M | $-23.09M | $-18.92M |
| Capital expenditures | $10664.00 | $6473.00 | $859872.00 | $61276.00 | $435771.00 | $961781.00 | $400810.00 | $2.28M | $483097.00 | $5.33M | $2.53M | $1.33M | $3.29M | $440000.00 | $64000.00 | $354000.00 | $413000.00 | $674000.00 | $565000.00 | $522000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $151059.00 | $134518.00 | $488564.00 | $638709.00 | $1.22M | $1.28M | $3.22M | $4.46M | $11.05M | $7.95M | $3.93M | $5.40M | $3.58M | $2.23M | $3.52M | $4.29M | $4.64M | $5.08M | $4.75M |
| Free cash flow | $-1.27M | $-1.25M | $-2.46M | $-4.32M | $-8.17M | $-14.56M | $-20.08M | $-31.79M | $-39.34M | $-49.88M | $-44.85M | $-31.84M | $-34.17M | $-32.39M | $-19.82M | $-23.91M | $646000.00 | $-29.24M | $-23.66M | $-19.44M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | $454000.00 | $34.41M | $40000.00 | $25.15M | $7.24M | — | $37000.00 | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | $1.15M | $23.99M | $12.74M | — | — | $-13.29M | $-14.37M | $23.15M | $23.11M | $-43.47M | — | — | — |